Evolus
EOLS
151 hedge funds and large institutions have $480M invested in Evolus in 2023 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 44 increasing their positions, 54 reducing their positions, and 14 closing their positions.
1,305% more call options, than puts
Call options by funds: $9.43M | Put options by funds: $671K
100% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 14
27% more capital invested
Capital invested by funds: $379M → $480M (+$101M)
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
10% more funds holding
Funds holding: 137 → 151 (+14)
6.94% more ownership
Funds ownership: 72.75% → 79.69% (+6.9%)
19% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 54
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$22.3M |
| 2 |
PA
Perceptive Advisors
New York
|
+$22.2M |
| 3 |
Morgan Stanley
New York
|
+$18.4M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$12.5M |
| 5 |
SFM
Soros Fund Management
New York
|
+$4.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Manhattan
New York
|
-$20.9M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$19M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$5.28M |
| 4 |
CP
Caligan Partners
New York
|
-$3.27M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
-$3.14M |
EOLS Hedge Fund Activity: Q4 2023 in Review
151 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Evolus (EOLS) for Q4 2023, worth a combined $480M — up 27% from $379M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new EOLS positions and 14 closed out — a net gain of 14 holders — while 44 added to existing stakes and 54 trimmed.
The largest buyer was Nantahala Capital Management, adding an estimated $22.3M. The largest seller was First Manhattan, exiting entirely with an estimated $20.9M sold.
- 151 institutional investors held Evolus (EOLS) as of Q4 2023, up from 137 in Q3 2023.
- Funds reported $480M of Evolus stock for Q4 2023, up 27% quarter-over-quarter.
- 28 funds opened new Evolus positions in Q4 2023 and 14 closed out, a net change of +14 holders.
- The largest Evolus buyer in Q4 2023 was Nantahala Capital Management, an estimated $22.3M added.
- The largest Evolus seller in Q4 2023 was First Manhattan, an estimated $20.9M sold.
Based on aggregated 13F filings for Q4 2023.